CCIA
EDIT icon

Campbell & Co Investment Adviser’s Editas Medicine EDIT Stock Holding History

Campbell & Co Investment Adviser’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-51,301
Closed -$520K – 1167
2023
Q4 		$520K Buy
+51,301
New +$450K 0.05% 690
2023
Q3 		– Sell
-12,023
Closed -$98.9K – 1006
2023
Q2 		$98.9K Buy
+12,023
New +$105K 0.02% 841
2022
Q1 		– Sell
-12,550
Closed -$333K – 746
2021
Q4 		$333K Buy
+12,550
New +$432K 0.11% 324

Other funds holding EDIT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Campbell & Co Investment Adviser's EDIT Position: Q1 2024 in Review

Campbell & Co Investment Adviser sold out of Editas Medicine (EDIT) in Q1 2024, closing a stake of 51,301 shares — an estimated $520K sold.

Campbell & Co Investment Adviser first reported a position in EDIT in Q4 2021 and held it in 3 quarters. The position peaked at $520K in Q4 2023. 225 funds tracked by Wall St. Rank hold EDIT as of Q1 2024.

  • Campbell & Co Investment Adviser reported no remaining Editas Medicine position as of Q1 2024 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 51,301 Editas Medicine shares in Q1 2024, an estimated $520K.
  • Campbell & Co Investment Adviser first reported a position in Editas Medicine in Q4 2021 and held it in 3 quarters.
  • Campbell & Co Investment Adviser's Editas Medicine position peaked at $520K in Q4 2023.
  • 225 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2024.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2024, filed 10 May 2024.